Juvena’s platform is applicable across a wide scope of disease indications. Juvena has focused initially on mapping secreted proteins broadly across metabolic and rare chronic diseases. We’re excited to explore partnerships with biopharma companies looking to benefit from the mapping of secreted proteins to therapeutic focus areas.
